29.4 C
New York
Thursday, June 11, 2026

Tag: activity

Taking Time to Turn a Page: How U.S. Readers are Attempting to Slow Down Summer

For readers, books may be one of the simplest ways to bring back that endless summer feeling.

Ormat Technologies Accelerates Enhanced Geothermal System (EGS) Deployments and Introduces Ormega100 Unit to Commercialize and Scale the Largest Binary Unit in the Industry

RENO, Nev., June 08, 2026 (GLOBE NEWSWIRE) -- Ormat Technologies, Inc. (NYSE: ORA) (the “Company” or “Ormat”), a leading geothermal and renewable energy company and the only vertically integrated designer, builder, owner, and operator of geothermal facilities in the world, today announced the Ormega100, a revolutionary new surface power generation unit engineered to deliver higher output than any other binary solution currently on the market. The Ormega100 marks an accelerated opportunity to commercialize and scale its Enhanced Geothermal System (EGS) developments, connecting subsurface development with surface power generation at an accelerated pace.

Agent Governance Platform from Ares® Networks Now Available in the Microsoft Marketplace

Microsoft Azure customers worldwide can now discover and deploy the Ares® Networks Agent Governance Platform through Microsoft Marketplace, accessing trusted solutions that accelerate innovation...

Reco Expands Executive Team and Global Footprint to Accelerate Leadership in Enterprise AI Agent Security

Company appoints COO and new executive team, opens Texas office, expands into UKI, and earns top national reseller rankings. Recognized with three Global InfoSec Awards.NEW...

Liquid-applied Membrane Market worth $35.47 billion by 2031 – Exclusive Report by MarketsandMarkets™

DELRAY BEACH, Fla., June 8, 2026 /PRNewswire/ -- According to MarketsandMarkets, "Liquid-applied Membrane Market by Type (Bituminous, Elastomeric, Cementitious), Application (Roofing, Walls, Roadways), Usage (New...

Liquid-applied Membrane Market worth $35.47 billion by 2031 – Exclusive Report by MarketsandMarkets™

DELRAY BEACH, Fla., June 8, 2026 /PRNewswire/ -- According to MarketsandMarkets, "Liquid-applied Membrane Market by Type (Bituminous, Elastomeric, Cementitious), Application (Roofing, Walls, Roadways), Usage (New...

Artiva Biotherapeutics Highlights AlloNK® Data Presented at EULAR 2026, FDA RMAT Designation in Refractory Rheumatoid Arthritis and Webcast Today

Artiva Biotherapeutics Highlights AlloNK® Data Presented at EULAR 2026, FDA RMAT Designation in Refractory Rheumatoid Arthritis and Webcast Today

Black Castle Capital Partners Celebrates Successful Launch of Kabuni Sports at PLAYTIME 2026 in Mumbai

From Mumbai to the world: Kabuni Sports launched its AI-powered sports ecosystem, redefining how the next generation learns, trains and competes.

Kali Therapeutics Announces Poster Presentation of KT209, a Novel CD19 x CD20 x CD3 Trispecific Antibody, at the EHA 2026 Annual Congress

SAN MATEO, Calif., June 8, 2026 /PRNewswire/ -- Kali Therapeutics, a clinical-stage biotechnology company pioneering next-generation immune-resetting and multi-specific therapies, today announced that preclinical...

Foresee’s Oral ALDH2 Activator, Mirivadelgat to Enter Clinical Testing in Parkinson’s Disease in the SLEIPNIR Phase 2a Platform Trial

TAIPEI, June 8, 2026 /PRNewswire/ -- Foresee Pharmaceuticals (6576.TWO), ("Foresee") announced today that Foresee's oral ALDH2 activator, mirivadelgat, has been selected to enter clinical testing in...

TotalEnergies ENEOS Extends Solar Partnership with Ceres in Indonesia

BANDUNG, Indonesia, June 8, 2026 /PRNewswire/ -- TotalEnergies ENEOS successfully completed Phase 2 of a rooftop solar photovoltaic (PV) project with PT. Perusahaan Industri Ceres...

Sapu Nano Expands International Development of Sapu003 and Appoints Global Clinical Trials (GCT) as Lead CRO for Phase 1b Program

SAN DIEGO, June 8, 2026 /PRNewswire/ -- Sapu Bioscience LLC announced the expansion of its Phase 1b clinical development program for Sapu003 (Everolimus for...

Lilly’s Foundayo (orforglipron), the only oral GLP-1 taken without food or water restrictions, was associated with significant weight loss in women at every stage...

In ATTAIN-1, women in perimenopause taking Foundayo lost up to 30.4 lbs (14.4%) and those in post-menopause lost up to 28.2 lbs (14.1%)In ATTAIN-2, women taking Foundayo lost significant...

Wegovy® pill prescriptions surpass 3 million, 1 filled roughly every 5 seconds, bringing GLP-1 therapy to people with obesity previously untreated, while Novo Nordisk...

Three million prescriptions for Wegovy® pill since launch on January 5th serves as another milestone in one of the strongest US pharmaceutical launches by...

- A word from our sponsors -

spot_img
HomeTagsActivity